Table 2.
Summary of demographic data.
| No. of Patients | 151 |
|---|---|
| Median age, y (range) | 62 (41–83) |
| Median PSA, ng/mL (range) | 6.8 (0.9–28.5) |
| Highest Gleason grade at histopathology (%) | |
| Benign | 22 (15) |
| 3 + 3 | 53 (35) |
| 3 + 4 | 63 (42) |
| ≥4 + 3 | 13 (8) |
| Definition 1 * csPCa | 60 (40) |
| Definition 2 ** csPCa | 95 (63) |
| Any Gleason ≥ 3 + 4 | 76 (50) |
| Median no. of positive cores (IQR) | 6 (2–11) |
| Median MCCL (IQR) | 4 (1.5–7) |
* Gleason ≥ 4 + 3 and/or cancer core length (CCL) involvement ≥ 6 mm. ** Gleason ≥ 3 + 4 and/or CCL ≥ 4 mm. csPCa: clinically significant prostate cancer; IQR: interquartile range; MCCL: maximum cancer core length.